Abbott announced that Robert B. Ford has been named president and chief operating officer, effective immediately. Ford, a 22-year Abbott veteran, was most recently executive vice president of Medical Devices, Abbott’s largest…Read More
Luminex Corporation announced that it expects to report results for the third quarter ended September 30, 2018 on Monday, November 5, 2018. A press release announcing the results is scheduled for release after…Read More
Qiagen N.V. announced the European rollout of its next-generation QIAstat-Dx panel for one-step, fully integrated molecular analysis of gastrointestinal (GI) syndromes. The multiplex gastrointestinal panel, which Qiagen has upgraded to now…Read More
Amgen announced that AMGEVITA, a biosimilar to adalimumab, will launch in markets across Europe beginning on Oct. 16, 2018. AMGEVITA is the first adalimumab biosimilar to be approved by the European Commission (EC). AMGEVITA…Read More
The board of directors of Eli Lilly and Company has declared a dividend for the fourth quarter of 2018 of USD 0.5625 per share on outstanding common stock. The dividend is payable December…Read More
Allogene Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) therapies for cancer, announced the closing of its previously announced initial public offering of…Read More
The FDA continues to advance new policies, modernize our programs and advance opportunities for developing more targeted therapies. Using new technology platforms such as cell and gene therapies and small…Read More
Sysmex Inostics, a pioneer in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, is pleased to announce publication of a study in the Journal of Molecular Oncology…Read More
Phoenix PharmaLabs, a privately-held pre-clinical drug discovery company dedicated to the development of potent, non-addictive treatment for pain and treatments for addiction, announced the launch of an equity offering campaign…Read More
Cigna-HealthSpring, a leading provider of Medicare Advantage (MA) plans, introduced its 2019 plans with more comprehensive benefits and a new nationwide prescription drug plan delivering personalized, affordable and quality health…Read More
The data scientists and developers behind a ground-breaking microbiome data platform announced their partnership with Microsoft Genomics, a Microsoft Azure service dedicated to meeting the computational challenges of the genomics…Read More
Qiagen N.V. plans as previously announced to release its report on results for the third quarter 2018 on Monday, October 29 shortly after 21:00 Central European Time (CET)/16:00 Eastern Daylight…Read More
Getinge makes a provision of SEK 1.8 billion for expected costs associated with Atrium Medical Corporation surgical mesh product liability claims filed in the US and Canada. The suits consist of individual lawsuits,…Read More
Mylan N.V. announced that the United States Court of Appeals for the Federal Circuit has affirmed the District of Delaware’s decision that Teva’s Copaxone 40 mg/mL dosing patents are invalid…Read More
Varian announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs). The Noona patient software app lets clinics…Read More
Recent Comments